Sorry, this activity has expired and is no longer available for CME credit. You may still enjoy the program.
CME Information
Provider Statement: This continuing medical education activity is provided by 
.
Support Statement: This activity is supported by an educational grant from Bristol-Myers Squibb.
Target Audience: The intended audience for this activity is rheumatologists and other health care professionals involved in the treatment of patients with rheumatoid arthritis (RA).
Learning Objectives: Upon successful completion of this educational activity, participants should be better able to:
- Assess B-cell biology and its role in immune-mediated inflammatory diseases, including rheumatoid arthritis.
- Define immunogenicity in the context of biologic therapies and appraise its role in efficacy and toxicity.
- Apply clinical advances in the use of biologic therapy to optimize the treatment of rheumatoid arthritis.
Activity Chair:
Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
R.J. Fasenmyer Chair of Clinical Immunology
Theodore F. Classen DO Chair of Osteopathic Research and Education
Vice Chairman, Department of Rheumatic and Immunologic Diseases
Cleveland, OH
Faculty:
Jonathan Kay, MD
Professor of Medicine
University of Massachusetts Medical School
Director of Clinical Research,Division of Rheumatology
University of Massachusetts Medical School
Worcester, MA
Gregg J. Silverman, MD
Professor of Medicine and Pathology
Director, Laboratory of B-Cell Immunology
NYU Langone Medical Center
New York, NY
Reviewers:
Kevin D. Deane, MD, PhD
Ronald Codario, MD, FACP, FNLA, RPVI, CHCP (Recertification review on 8/15/2016)
Accreditation:
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation:
Vindico Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material was originally approved for 1 year from the date of original release, September 15, 2015 to September 15, 2016.
It has since been recertified for an additional 2 years and will now expire on July August 15, 2018.
How To Participate in this Activity and Obtain CME Credit:
To participate in this CME activity, you must read the objectives and articles, complete the CME posttest, and the evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 7 out of 10 of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.
The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.
Faculty reports the following relationship(s) which are accurate at the time of original content release (September 15, 2015):
Leonard H. Calabrese, DO
Consulting Fee: AbbVie, Bristol-Myers Squibb, Genentech, GlaxoSmithKline, Janssen, Pfizer, Sanofi
Speakers Bureau: AbbVie, Bristol-Myers Squibb, Crescendo, Genentech
Jonathan Kay, MD
Consulting Fees: AbbVie, Alexion Pharmaceuticals, Amgen, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Crescendo Bioscience, Inc., Eli Lilly, Epirus Biopharmaceuticals, Genentech, Hospira, Janssen, Merck, Nippon Kayaku, Novartis, PanGenetics, Pfizer, Samsung Bioepis, Roche, UCB
Contracted Research (paid directly to institution): AbbVie, Ardea Biosciences, Eli Lilly, Pfizer, Roche
Gregg J. Silverman, MD
Consulting Fees: Celgene, GlaxoSmithKline, Quest, Pfizer
Speakers Bureau: Roche
Reviewers report the following relationship(s):
Kevin D. Deane, MD, PhD
No relevant financial relationships to disclose.
Ronald Codario, MD, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Medical Writer reports the following relationship(s):
Valerie Zimmerman, PhD
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.
Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2015 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CME Questions?
Contact us at cme@vindicoCME.com